Patents by Inventor Robert Bernard Levine

Robert Bernard Levine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240000825
    Abstract: The present application relates to beta-1,3-glucan and uses thereof to modulate immunity in the human body. Also provided are methods for treatment and/or prevention of high cholesterol, diabetes, and allergies. Also provided are methods for treatment and/or prevention of intestinal inflammation.
    Type: Application
    Filed: August 4, 2023
    Publication date: January 4, 2024
    Applicant: KEMIN INDUSTRIES, INC.
    Inventors: Geoffrey Paul HORST, Robert Bernard LEVINE
  • Patent number: 11744847
    Abstract: The present application relates to beta-1,3-glucan and uses thereof to modulate immunity in the human body. Also provided are methods for treatment and/or prevention of high cholesterol, diabetes, and allergies. Also provided are methods for treatment and/or prevention of intestinal inflammation.
    Type: Grant
    Filed: January 22, 2021
    Date of Patent: September 5, 2023
    Assignee: KEMIN INDUSTRIES, INC.
    Inventors: Geoffrey Paul Horst, Robert Bernard Levine
  • Publication number: 20210346423
    Abstract: The present application relates to beta-1,3-glucan and uses thereof to modulate immunity in the human body. Also provided are methods for treatment and/or prevention of high cholesterol, diabetes, and allergies. Also provided are methods for treatment and/or prevention of intestinal inflammation.
    Type: Application
    Filed: January 22, 2021
    Publication date: November 11, 2021
    Inventors: Geoffrey Paul HORST, Robert Bernard LEVINE
  • Patent number: 10912794
    Abstract: The present application relates to beta-1,3-glucan and uses thereof to modulate immunity in the human body. Also provided are methods for treatment and/or prevention of high cholesterol, diabetes, and allergies. Also provided are methods for treatment and/or prevention of intestinal inflammation.
    Type: Grant
    Filed: October 27, 2016
    Date of Patent: February 9, 2021
    Assignee: KEMIN INDUSTRIES, INC.
    Inventors: Geoffrey Paul Horst, Robert Bernard Levine
  • Publication number: 20180311271
    Abstract: The present application relates to beta-1,3-glucan and uses thereof to modulate immunity in the human body. Also provided are methods for treatment and/or prevention of high cholesterol, diabetes, and allergies. Also provided are methods for treatment and/or prevention of intestinal inflammation.
    Type: Application
    Filed: October 27, 2016
    Publication date: November 1, 2018
    Inventors: Geoffrey Paul HORST, Robert Bernard LEVINE
  • Publication number: 20180280450
    Abstract: The present invention relates to compositions and methods for promoting the immune health of an animal or human by administering compositions or mixtures of water-soluble components derived from a genus Euglena organism that are capable of stimulating immune system activity in the absence of beta-glucan.
    Type: Application
    Filed: March 28, 2018
    Publication date: October 4, 2018
    Inventors: Robert Bernard LEVINE, Geoffrey Paul HORST, John A. MINATELLI, W. Stephen HILL, Patricia M. O'CONNELL
  • Publication number: 20170290853
    Abstract: The present application relates to methods to facilitate the solubilization of beta-1,3-glucan in solution, for instance an aqueous or organic solvent and uses thereof to enhance immune function in an individual. Others aspects of the present invention relate to administering compositions or mixtures comprising solubilized beta-1,3-glucan to enhance immune function in humans or animals.
    Type: Application
    Filed: April 12, 2017
    Publication date: October 12, 2017
    Inventors: Geoffrey Paul HORST, Robert Bernard LEVINE
  • Patent number: 9574217
    Abstract: Immune function of an animal can be modulated by administration of a composition that includes algae meal or beta glucan. The algae meal can be made by growing Euglena using particular methods and conditions, including certain continuous, semi-continuous, fed-batch, and repeat batch methods in sterile fermenters. Euglena provides a form of beta glucan that is different from other organisms, where the beta glucan is predominantly unbranched beta-1,3-glucan. Use of algae meal and beta glucan produced by the disclosed processes can improve the wellbeing of an animal or human, and may augment or even replace the use of antibiotics in certain circumstances.
    Type: Grant
    Filed: May 7, 2013
    Date of Patent: February 21, 2017
    Assignee: Algal Scientific Corporation
    Inventors: Robert Bernard Levine, Jeffrey Richard LeBrun, Geoffrey Paul Horst
  • Publication number: 20160122703
    Abstract: An organic waste and wastewater treatment method and system that quickly and cost-effectively removes most organic materials from a waste or wastewater while generating a gaseous byproduct that can be used for heat or electricity generation. The method and system begins with a maceration and/or screening step that reduces waste particle size. Then, the waste is pumped through orifice(s) under high pressure to emulsify the waste and covert it to a slurry. The slurry is then treated in a horizontal anaerobic digester with flexible support material for microbial attachment to remove organic materials.
    Type: Application
    Filed: October 2, 2015
    Publication date: May 5, 2016
    Inventor: Robert Bernard Levine